| Dr Winona Wong, MD, PHD | |
|
2525 S King St, Suite 304, Honolulu, HI 96826-3154 | |
| (808) 791-3364 | |
| (808) 791-3366 |
| Full Name | Dr Winona Wong |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 2525 S King St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568439974 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD13301 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Winona Wong, MD, PHD 2525 S King St, Suite 304, Honolulu, HI 96826-3154 Ph: (808) 791-3367 | Dr Winona Wong, MD, PHD 2525 S King St, Suite 304, Honolulu, HI 96826-3154 Ph: (808) 791-3364 |
News Archive
Mindful of lessons from a failed heart drug that cost $800 million to develop, drug companies are taking another shot at new medications that boost levels of so-called "good cholesterol," which removes cholesterol from the body.
Babies born to obese mothers may have an increased risk of asthma, according to data from a new study to be presented on May 19 at the 105th International Conference of the American Thoracic Society in San Diego.
Drug company GlaxoSmithKline have had a good result with their new vaccine which was designed to prevent infection with the virus that causes cervical cancer.
In a world first, researchers from The University of Western Australia have taken the first step towards understanding whether it may be possible for breastfeeding mothers to naturally vaccinate their babies against malaria – one of the world's deadliest contagious diseases.
Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.
› Verified 2 days ago
Dr. Jay L. Grekin, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4360 Fax: 808-522-3361 | |
Bradley S. Lau, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Geoffrey Strider Farnsworth, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Honolulu, HI 96819 Phone: 808-433-6661 | |
Dr. Linda E. Fancher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1010 S King St Ste 220, Honolulu, HI 96814 Phone: 808-597-8038 Fax: 808-596-2387 | |
Janice Matsunaga, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1329 Lusitana St, Suite 507, Honolulu, HI 96813 Phone: 808-532-0155 Fax: 808-532-0160 | |
Dr. Iris Kimhayoung Noh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4360 | |
Dylan Lee, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1380 Lusitana St Ste 401, Honolulu, HI 96813 Phone: 808-531-7541 Fax: 808-531-7542 |